Company Analysis

Vir Biotechnology, Inc. (VIR)

Nasdaq: VIR · Biological Products, (No Diagnostic Substances) · San Francisco, CA · filing with the SEC since 2018
Grade5.2
◀ Past 7.1● Present 4.3▶ Future 4.5
1 est.

Filings

244 filings since 2017 beside 562 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 16, 2026.

Filings a yearinsider forms included
661261401031067286106
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 11 times in the last 36 months, the newest Oct 28, 2026.
Insider forms 562

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 424B5 Shelf offering
Nov 12, 2026 S-3ASR Shelf registration
Nov 10, 2026 SCHEDULE 13G Large holder notice
Nov 9, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Nov 8, 2026
Nov 6, 2026 SCHEDULE 13D/A Activist holder update, amended
Nov 4, 2026 10-Q Quarterly report Sep 30, 2026
Nov 4, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 28, 2026 8-K item 5.02 Officer or director change · Current report Oct 26, 2026
Oct 27, 2026 SCHEDULE 13G/A Large holder update, amended
Oct 14, 2026 8-K items 3.02, 8.01, 9.01 Shares sold without registration; Other event · Current report Oct 9, 2026
Oct 8, 2026 8-K items 8.01, 9.01 Other event · Current report
Oct 1, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report
Aug 7, 2026 SCHEDULE 13G Large holder notice
Aug 5, 2026 10-Q Quarterly report Jun 30, 2026
Aug 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Jul 31, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 24, 2026 8-K item 5.02 Officer or director change · Current report Jul 20, 2026
Jun 10, 2026 8-K item 5.02 Officer or director change · Current report Jun 9, 2026
May 28, 2026 8-K items 5.02, 5.07 Officer or director change; Shareholder vote · Current report May 25, 2026
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 29, 2026 SCHEDULE 13G Large holder notice
Apr 16, 2026 DEFA14A Extra proxy material
Apr 16, 2026 DEF 14A Proxy statement Dec 31, 2025
Apr 16, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 10, 2026 8-K item 5.02 Officer or director change · Current report Apr 7, 2026
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 4, 2026 8-K item 5.02 Officer or director change · Current report
Mar 3, 2026 SCHEDULE 13D/A Activist holder update, amended
Mar 2, 2026 8-K item 8.01 Other event · Current report Feb 26, 2026
Feb 26, 2026 8-K items 1.01, 9.01 Major agreement signed · Current report Feb 25, 2026
Feb 26, 2026 424B5 Shelf offering
Feb 24, 2026 424B5 Shelf offering
Feb 23, 2026 S-8 Employee stock plan registration
Feb 23, 2026 10-K Annual report Dec 31, 2025
Feb 23, 2026 8-K items 1.01, 2.02, 3.02, 8.01, 9.01 Major agreement signed; Results released; Shares sold without registration; Other event · Current report Feb 19, 2026
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 12, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Dec 16, 2025 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report
40 of 244 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton VIR · research, not advice